Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Type of study
Language
Publication year range
1.
Eur J Pharmacol ; 888: 173460, 2020 Dec 05.
Article in English | MEDLINE | ID: mdl-32805257

ABSTRACT

This study sought to examine the co-expression of the following purinergic receptor subunits: P2X1, P2X1del, P2X4, and P2X7 and characterize the P2X response in human monocyte-derived macrophages (MDMs). Single-cell RT-PCR shows the presence of P2X1, P2X1del, P2X4, and P2X7 mRNA in 40%, 5%, 20%, and 90% of human MDMs, respectively. Of the studied human MDMs, 25% co-expressed P2X1 and P2X7 mRNA; 5% co-expressed P2X4 and P2X7; and 15% co-expressed P2X1, P2X4, and P2X7 mRNA. In whole-cell patch clamp recordings of human MDMs, rapid application of ATP (0.01 mM) evoked fast current activation and two different desensitization kinetics: 1. a rapid desensitizing current antagonized by PPADS (1 µM), reminiscent of the P2X1 receptor's current; 2. a slow desensitizing current, insensitive to PPADS but potentiated by ivermectin (3 µM), similar to the P2X4 receptor's current. Application of 5 mM ATP induced three current modalities: 1. slow current activation with no desensitization, similar to the P2X7 receptor current, present in 69% of human macrophages and antagonized by A-804598 (0.1 µM); 2. fast current activation and fast desensitization, present in 15% of human MDMs; 3. fast activation current followed by biphasic desensitization, observed in 15% of human MDMs. Both rapid and biphasic desensitization kinetics resemble those observed for the recombinant human P2X1 receptor expressed in oocytes. These data demonstrate, for the first time, the co-expression of P2X1, P2X4, and P2X7 transcripts and confirm the presence of functional P2X1, P2X4, and P2X7 receptors in human macrophages.


Subject(s)
Macrophages/metabolism , Receptors, Purinergic P2X1/biosynthesis , Receptors, Purinergic P2X4/biosynthesis , Receptors, Purinergic P2X7/biosynthesis , Adenosine Triphosphate/pharmacology , Animals , Cells, Cultured , Female , Gene Expression , Humans , Macrophages/drug effects , Purinergic P2X Receptor Agonists/pharmacology , Receptors, Purinergic P2X1/genetics , Receptors, Purinergic P2X4/genetics , Receptors, Purinergic P2X7/genetics , Xenopus laevis
2.
Purinergic Signal ; 10(4): 565-72, 2014 Dec.
Article in English | MEDLINE | ID: mdl-24845338

ABSTRACT

Stimulation of P2X receptors by ATP in vascular smooth muscle cells (VSMCs) is proposed to mediate vascular tone. However, understanding of P2X receptor-mediated actions in human blood vessels is limited, and therefore, the current work investigates the role of P2X receptors in freshly isolated small human gastro-omental arteries (HGOAs). Expression of P2X1 and P2X4 receptor subunit messenger RNA (mRNA) and protein was identified in individual HGOA VSMCs using RT-PCR and immunofluorescent analysis and using Western blot in multi-cellular preparations. ATP of 10 µmol/l and αß-meATP of 10 µmol/l, a selective P2X receptor agonist, evoked robust increases in [Ca(2+)]i in fluo-3-loaded HGOA VSMCs. Pre-incubation with 1 µmol/l NF279, a selective P2X receptor antagonist, reduced the amplitude of αß-meATP-induced increase in [Ca(2+)]i by about 70 %. ATP of 10 µmol/l and αß-meATP of 10 µmol/l produced similar contractile responses in segments of HGOA, and these contractions were greatly reduced by 2 µmol/l NF449, a selective P2X receptor inhibitor. These data suggest that VSMCs from HGOA express P2X1 and P2X4 receptor subunits with homomeric P2X1 receptors likely serving as the predominant target for extracellular ATP.


Subject(s)
Arteries/metabolism , Muscle, Smooth, Vascular/metabolism , Receptors, Purinergic P2X1/biosynthesis , Receptors, Purinergic P2X4/biosynthesis , Blotting, Western , Female , Fluorescent Antibody Technique , Humans , Male , Middle Aged , Omentum/blood supply , Omentum/metabolism , Reverse Transcriptase Polymerase Chain Reaction , Vasoconstriction
3.
Pain ; 152(9): 2085-2097, 2011 Sep.
Article in English | MEDLINE | ID: mdl-21669492

ABSTRACT

Extracellularly released adenosine triphosphate (ATP) modulates sensory signaling in the spinal cord. We analyzed the spatiotemporal profiles of P2X receptor-mediated neuronal and glial processing of sensory signals and the distribution of P2X receptor subunits in the rat dorsal horn. Voltage imaging of spinal cord slices revealed that extracellularly applied ATP (5-500 µM), which was degraded to adenosine and acting on P1 receptors, inhibited depolarizing signals and that it also enhanced long-lasting slow depolarization, which was potentiated after ATP was washed out. This post-ATP rebound potentiation was mediated by P2X receptors and was more prominent in the deep than in the superficial layer. Patch clamp recording of neurons in the superficial layer revealed long-lasting enhancement of depolarization by ATP through P2X receptors during the slow repolarization phase at a single neuron level. This depolarization pattern was different from that in voltage imaging, which reflects both neuronal and glial activities. By immunohistochemistry, P2X(1) and P2X(3) subunits were detected in neuropils in the superficial layer. The P2X(5) subunit was found in neuronal somata. The P2X(6) subunit was widely expressed in neuropils in the whole gray matter except for the dorsal superficial layer. Astrocytes expressed the P2X(7) subunit. These findings indicate that extracellular ATP is degraded into adenosine and prevents overexcitation of the sensory system, and that ATP acts on pre- and partly on postsynaptic neuronal P2X receptors and enhances synaptic transmission, predominantly in the deep layer. Astrocytes are involved in sensitization of sensory network activity more importantly in the superficial than in the deep layer.


Subject(s)
Neuroglia/physiology , Posterior Horn Cells/physiology , Receptors, Purinergic P2X1/physiology , Receptors, Purinergic P2X3/physiology , Receptors, Purinergic P2X5/physiology , Receptors, Purinergic P2X7/physiology , Receptors, Purinergic P2/physiology , Sensory Receptor Cells/physiology , Animals , Brain Chemistry/genetics , Brain Chemistry/physiology , Female , Male , Neuroglia/chemistry , Neuroglia/metabolism , Neurons/chemistry , Neurons/metabolism , Neurons/physiology , Posterior Horn Cells/chemistry , Rats , Rats, Wistar , Receptors, Purinergic P2/biosynthesis , Receptors, Purinergic P2X1/biosynthesis , Receptors, Purinergic P2X3/biosynthesis , Receptors, Purinergic P2X5/biosynthesis , Receptors, Purinergic P2X7/biosynthesis , Sensory Receptor Cells/chemistry , Spinal Cord/chemistry , Spinal Cord/metabolism , Spinal Cord/physiology , Time Factors
4.
Circ J ; 75(4): 945-54, 2011.
Article in English | MEDLINE | ID: mdl-21378451

ABSTRACT

BACKGROUND: The experimental pulmonary hypertension that develops in hypobaric hypoxia is characterized by structural remodeling of the heart. The P2X4 receptor (P2X4R) controls vascular tone and vessel remodeling in several blood vessels, and it has emerged as a key factor in the enhancement of cardiovascular performance. METHODS AND RESULTS: To study the possible effects of hypobaric hypoxia on the P2X4R-synthesis system, 150 male Wistar rats were housed in a chamber at the equivalent of the 5,500 m altitude level for 21 days. After 14 days' exposure to hypobaric hypoxia, pulmonary arterial pressure (PAP) was significantly increased. In the right ventricle (RV) of the heart, P2X4R expression was significantly increased on days 1 and 14 (mRNA) and on days 7 and 21 (protein) of hypobaric hypoxic exposure. Immunohistochemical staining for P2X4R protein became more intense in RV in the late phase of exposure. These changes in P2X4R synthesis in RV occurred alongside the increase in PAP. In addition, P2X1R and P2Y2R mRNA levels in the RV were significantly increased on days 1, 14, and 21, and day 5, respectively, of exposure. The level of P2X1R protein in the RV was significantly increased on day 21 of exposure. CONCLUSIONS: Conceivably, P2 receptors, including P2X4R and P2X1R, might play roles in modulating the RV hypertrophy that occurs due to pulmonary hypertension in hypobaric hypoxia.


Subject(s)
Gene Expression Regulation , Heart Ventricles/metabolism , Hypertension, Pulmonary/metabolism , Hypoxia/metabolism , Muscle Proteins/biosynthesis , RNA, Messenger/biosynthesis , Receptors, Purinergic P2X4/biosynthesis , Altitude Sickness/complications , Altitude Sickness/metabolism , Altitude Sickness/pathology , Animals , Heart Ventricles/pathology , Hypertension, Pulmonary/etiology , Hypertension, Pulmonary/pathology , Hypertrophy, Right Ventricular/etiology , Hypertrophy, Right Ventricular/metabolism , Hypertrophy, Right Ventricular/pathology , Hypoxia/complications , Hypoxia/pathology , Lung/metabolism , Lung/pathology , Male , Rats , Rats, Wistar , Receptors, Purinergic P2X1/biosynthesis , Receptors, Purinergic P2Y2/biosynthesis , Time Factors
SELECTION OF CITATIONS
SEARCH DETAIL
...